BIOVECTRA
Benjamin Johnston is a Senior Scientist at BIOVECTRA since January 2022, specializing in Biologics PSDS. Prior to this role, Benjamin was a Postdoctoral Research Fellow at the University of Prince Edward Island from June 2019 to January 2022. Benjamin obtained a PhD in Microbiology and Immunology from Dalhousie University from 2012 to 2019, following a BSc in the same field from the same institution from 2009 to 2012. Benjamin also holds a BSc in Biomedical Sciences from the University of Guelph, completed from 2005 to 2007.
BIOVECTRA
BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemicaland biologic molecules, downstream processing, MPEG production, and conjugation chemistry.BioVectra was founded on 1970 and is based in Charlottetown, Canada.